Inventor · disambiguated record
Antoine Attinger
Also filed as: ATTINGER ANTOINE
4 granted patents·7 pending applications·59 citations·filing 2012–2025
76Inventor score
Files withGLENMARK PHARMACEUTICALS SA5Ichnos Sciences SA3ATTINGER ANTOINE1DEBIOPHARM INT SA1SCHERRER INST PAUL1
Top patents by PatentIndex Score
11 records- 0192US9290576B2Antibodies that bind to TL1A and their usesGLENMARK PHARMACEUTICALS SA·Filed 2014·Granted Mar 22, 2016·22 cites·51 claims
- 0292US8748585B2Antibodies that bind to OX40 and their usesATTINGER ANTOINE·Filed 2012·Granted Jun 10, 2014·36 cites·68 claims
- 0382US11407839B2Antibodies that bind to OX40 and their usesIchnos Sciences SA·Filed 2019·Granted Aug 9, 2022·1 cites·30 claims
- 0481US12281169B2Antibodies that bind to OX40 and their usesIchnos Sciences SA·Filed 2022·Granted Apr 22, 2025·0 cites·28 claims
- 0577US2025250351A1Antibodies that bind to ox40 and their usesIchnos Sciences SA·Filed 2025·Application pending·0 cites
- 0662US2014294824A1Antibodies that bind to ox40 and their usesGLENMARK PHARMACEUTICALS SA·Filed 2014·Application pending·0 cites
- 0758US2017260280A1Antibodies that Bind to OX40 and Their UsesGLENMARK PHARMACEUTICALS SA·Filed 2016·Application pending·0 cites
- 0857US2020079863A1Antibodies that bind to tl1a and their usesGLENMARK PHARMACEUTICALS SA·Filed 2019·Application pending·0 cites
- 0955US2024401145A1Method for predicting the response of a patient diagnosed with cancer to treatment and/or imaging with a compound targeting cck2-r, and compound for use in methods of selectively treating and/or imaging cancerSCHERRER INST PAUL·Filed 2021·Application pending·0 cites
- 1051US2023270893A1Gallium-labeled gastrin analogue and use in a method of imaging cckb-receptor-positive tumors or cancersDEBIOPHARM INT SA·Filed 2021·Application pending·0 cites
- 1151US2018086840A1Antibodies that bind to tl1a and their usesGLENMARK PHARMACEUTICALS SA·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Antoine Attinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →